News & Events

 After half a century of service to VUMC, the Department of Health Policy is hosting a retirement symposium to honor Professor Wayne Ray, PhD, celebrating his decades of research and contributions to the medical center and its research.

The Department of Health Policy at Vanderbilt University’s School of Medicine is conducting an open-rank search for ASSISTANT, ASSOCIATE or FULL PROFESSORS with expertise in health policy.

A Vanderbilt study published in the American Journal of Epidemiology unveils ne

The majority of Tennessee parents take their children to their primary care provider or pediatrician when they are sick, but the latest analysis of polling by the Vanderbilt Center for Child Health Policy of parents across the state suggests there are misconceptions about antibiotics, and their use in treating viral infections.

Over 40% of Tennessee families with children say they are food insecure; 70% have changed spending on food by Jake Lowary This year’s Vanderbilt Child Health Poll shows that over 40% of Tennessee families report they are food insecure ― a similar proportion from last year. Most families (71%) say they have continued to change food spending habits due to high prices.

 

(Originally published in March 2023.) Stacie Dusetzina, PhD, Ingram Professor of Cancer Research and Professor of Health Policy, joined Mark Cuban, billionaire and founder of Cost Plus Drugs Co., and Ruchika Talwar, MD, Urologic Oncology fellow in VUMC’s Department of Urology, for a lecture and discussion on the efforts to reduce prescription drug prices for Americans.

For years, Professor John Graves, PhD, has been studying health care markets and the policies that influence them. Using statistical models and data from multiple sources, Graves develops models to inform decision-makers and policymakers.

A May 2023 study from Vanderbilt University Medical Center researchers published in the Annals of Internal Medicine examining the cost-effectiveness of testing for some hereditary cancers and hypocholesterolemia was recognized as one of the 10 “most significant” pieces of genomics research by a working group at the National Institutes of Health.

In early January 2024, the Food and Drug Administration said it would allow Florida to import some medications from Canada, where they are cheaper than buying in the U.S. It is the first U.S. state to import drugs in bulk, and has raised both acclaim and concern. Stacie Dusetzina, PhD, Professor of Health Policy, explains with CBS News how this policy can impact Florida taxpayers and who stands to benefit most from the expected lower prices of some certain drugs.